Atze Bijker
Netherlands
๐— ๐—ฎ๐—ป๐˜† ๐—ผ๐—ณ ๐˜†๐—ผ๐˜‚ ๐—ฑ๐—ผ ๐—ป๐—ผ๐˜ ๐—ธ๐—ป๐—ผ๐˜„ ๐˜๐—ต๐—ถ๐˜€ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐˜† ๐Ÿ‘€ This small company in the biotech sector is gaining ground. Itโ€™s still cheap. Today it announced a collaboration with $ORCL (Oracle Corporation) and $AMD (Advanced Micro Devices Inc) . And last year AMD invested 20 million in this company. The company is $ABSI (Absci Corp) . Its a data-first generative drug creation company. Here are some important things to know about Absci: 1. Balance sheet is large, enough to support itself untill half of 2027. 2. Average price target of 8 from analyst 3. Recent offering was at 3.00 Now the chart is in a downtrend, but itโ€™s drug results are promising. Backed by 2 tech giants. I believe this trend will break in time. If you ask me, this is a great long term hold.
3 replies
null
.